Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2025-12-17 @ 4:11 AM
Study NCT ID:
NCT06351696
Status:
None
Last Update Posted:
2024-04-09 00:00:00
First Post:
2024-04-02 00:00:00
Brief Title:
The Effects of Bromelain Supplement in Patients With Ulcerative Colitis
Sponsor:
National Nutrition and Food Technology Institute
Organization:
National Nutrition and Food Technology Institute
Study Overview
Official Title:
The Effects of Low FODMAP Diets Accompanied With and Without Bromelain Supplement on Quality of Life, Disease Activity Index and Inflammation in Patients With Ulcerative Colitis With and Without Primary Sclerosis Cholangitis
Status:
None
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlein or placebo along with low FODMAP diet for 8 weeks.
IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.
IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None